NCT06346977View on ClinicalTrials.gov

Diagnosis of Leptomeningeal Metastasis and the Monitoring of Intrathecal Chemotherapy Efficacy in NSCLC

Not yet recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

Diagnosis

Interventions

DRUG

Pemetrexed

Intrathecal injection of pemetrexed

Trial Locations (1)

430000

Union hospital, Wuhan

All Listed Sponsors

lead

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

OTHER

NCT06346977 - Diagnosis of Leptomeningeal Metastasis and the Monitoring of Intrathecal Chemotherapy Efficacy in NSCLC | Biotech Hunter | Biotech Hunter